Affymetrix Q1 Sales Up 2 Percent on Next-Gen Genotyping, Instrument Demand

The increase came despite a decline in sales of services and expression arrays for biomarker discovery projects.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.